Mr. Nemiroff has been an analyst at MAK Capital, the New York-based investment advisory firm, since 2016.  He has been in the investments business since 2008. He serves as a director for Noveome Biotherapeutics, Inc and Trailhead Biosystems. Previously, Mr. Nemiroff was a Director of Business Development at student lender MRU Holdings and a Manager of Corporate Development at Capital One Financial. Mr. Nemiroff was a strategy consultant at the Boston Consulting Group and practiced corporate law at the firm of Davis Polk & Wardwell in New York. Mr. Nemiroff graduated from Yale Law School and from Princeton University with a degree in economics.